Monoclonal antibodies in cancer immunotherapy
Crossref DOI link: https://doi.org/10.1007/s11033-018-4427-x
Published Online: 2018-10-11
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kimiz-Gebologlu, Ilgin
Gulce-Iz, Sultan
Biray-Avci, Cigir http://orcid.org/0000-0001-8251-4520
Text and Data Mining valid from 2018-10-11
Article History
Received: 5 June 2018
Accepted: 5 October 2018
First Online: 11 October 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.